Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06569121 · ClinicalTrials.gov registry record · NA

Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)

A NA study of Stroke and Stroke, Acute, sponsored by Baylor Research Institute.

Recruiting
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT06569121 is a NA study of Stroke and Stroke, Acute that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 94 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06569121, a NA study of Stroke and Stroke, Acute, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.

Interventions

  • BEHAVIORAL Group Lifestyle Balance for People Post Stroke (GLB-CVA)

Study Locations (1)

Texas

  • Baylor Scott & White Research Institute - Dallas

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2024-12-07
Est. Completion 2029-12-31
Phase NA

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT06569121

The ClinicalTrials.gov registry entry for NCT06569121 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Group Lifestyle Balance for People Post Stroke (GLB-CVA) is the first listed.

NCT06569121 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06569121 about?

NCT06569121 is a clinical study titled "Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)". Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.

What is the current status of trial NCT06569121?

This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2024-12-07. Estimated completion is 2029-12-31.

What conditions does trial NCT06569121 study?

This clinical trial studies the following conditions: Stroke, Stroke, Acute, Stroke, Cardiovascular, Stroke/Brain Attack, Stroke (CVA) or TIA.

What interventions are being tested in trial NCT06569121?

The interventions under investigation include: Group Lifestyle Balance for People Post Stroke (GLB-CVA) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06569121?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06569121 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.